Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001651308-24-000145·BeOne Medicines Ltd.
Schedule 13D ownership disclosure
CYPHERPUNK TECHNOLOGIES INC
Common Stock, par value $0.001 per share · CUSIP: 52187K200
Event date: 2024-10-31
- Filing-level shares
- 1,215,306.00
- Percent of class
- 0.0%
- BeiGene, Ltd.Reported CIK 0001651308
Shares: 1,215,306.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001651308-24-000145
- Form type
- SCHEDULE 13D/A
- Filer
- BeOne Medicines Ltd.
- CIK
- CIK 1651308
- Filed
- Oct 31, 2024
- Reporting period
- Oct 31, 2024
- Description
- Schedule 13D beneficial ownership